429673-82-5 Usage
Uses
Used in Organic Synthesis:
(3S,4S)-tert-butyl 3-(tert-butoxycarbonyl(Methyl)aMino)-4-hydroxypyrrolidine-1-carboxylate is used as a protecting group to prevent unwanted reactions and selectively modify functional groups in organic synthesis. Its presence ensures that specific reactions occur without affecting other parts of the molecule, facilitating the synthesis of complex organic compounds.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, (3S,4S)-tert-butyl 3-(tert-butoxycarbonyl(Methyl)aMino)-4-hydroxypyrrolidine-1-carboxylate serves as a building block for the synthesis of various organic compounds and pharmaceuticals. Its unique structure and functional groups contribute to the development of new drugs and therapeutic agents, enhancing the range of available treatments for different medical conditions.
Used in Laboratory Settings:
Due to the presence of the tert-butyl and tert-butoxycarbonyl groups, (3S,4S)-tert-butyl 3-(tert-butoxycarbonyl(Methyl)aMino)-4-hydroxypyrrolidine-1-carboxylate is relatively stable and easy to handle in laboratory settings. This makes it a preferred choice for researchers and chemists working on the synthesis and modification of organic compounds, ensuring safety and ease of use during experiments and chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 429673-82-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,9,6,7 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 429673-82:
(8*4)+(7*2)+(6*9)+(5*6)+(4*7)+(3*3)+(2*8)+(1*2)=185
185 % 10 = 5
So 429673-82-5 is a valid CAS Registry Number.
429673-82-5Relevant articles and documents
STABLE SNS-595 COMPOSITIONS AND METHODS OF PREPARATION
-
, (2011/04/14)
Methods of preparing substantially pure SNS-595 substance are disclosed. Also provided are compositions comprising SNS-595 substance that are substantially pure and essentially free of visible particles.
METHOD OF PREPARING (+)-1,4-DIHYDRO-7-[(3S,4S)-3METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
-
Page/Page column 37, (2010/08/04)
Methods of preparing (+)-1, 4-dihydro-7-[(3S,45)-3-methoxy-4-(methylamino)-1 - pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid are disclosed. Also provided are pharmaceutical compositions comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid, and methods of treatment using such compositions.
Practical synthesis of (3S,4S)-3-methoxy-4-methylaminopyrrolidine
Tsuzuki, Yasunori,Chiba, Katsumi,Mizuno, Kazuhiro,Tomita, Kyoji,Suzuki, Kenji
, p. 2989 - 2997 (2007/10/03)
Three synthetic methods for the preparation of (3S,4S)-3-methoxy-4-methylaminopyrrolidine, an important intermediate in the synthesis of the novel quinolone antitumur agent, AG-7352, have been developed. By one route, an efficient and large-scale preparation of the chiral pyrrolidine could be achieved through resolution of (±)-1-Boc-3-benzylamino-4-hydroxypyrrolidine, which is prepared from either 3-pyrroline or 1,4-dichloro-2-butene.
